In patients with diabetes receiving chronic haemodialysis, both very high and low glucose
levels are associated with poor outcomes, including mortality. Conditions that are associated …

Patients with end-stage renal disease (ESRD) regardless of diabetes status are at increased
risk of hypoglycemia with a resultant array of adverse clinical outcomes. Therefore …

Background Patients with advanced diabetic kidney disease (DKD) behave differently to
diabetic patients without kidney disease. We aimed to investigate the associations of …

Objective: This review focuses on hypoglycemia in patients with end-stage renal disease
(ESRD). It discusses the pathophysiology of glucose metabolism in the kidney, the impact of …

Background. Hypoglycaemia (HG) has been demonstrated during chronic haemodialysis
(HD). These events may become more frequent with the current use of glucose-free …

OBJECTIVE There is a high risk of asymptomatic hypoglycemia associated with
hemodialysis (HD) using glucose-free dialysate; therefore, the inclusion of glucose in the …

Abnormal glycemic control in patients with advanced chronic renal diseases has been
recognized for almost 90 years (1). Nondiabetic patients with end-stage renal disease …

JCM | Free Full-Text | Hypoglycemia in Patients with Diabetes and Renal Disease Next Article
in Journal Addisonian Crisis after Missed Diagnosis of Posttraumatic Hypopituitarism Next …

Diabetes mellitus is the leading cause of end‐stage renal disease (ESRD) in the US and
many countries globally. The role of improved glycemic control in ameliorating the …

Diabetes mellitus (DM) is the most common cause of end-stage kidney disease and a major
risk of morbidity and mortality. It is not clear whether medical management of DM has any …